|
MayTuesday, May 15, 2012 Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012 Wednesday, May 02, 2012 Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection MarchThursday, Mar 29, 2012 Genentech's Trastuzumab Emtansine (T-DM1) Showed Positive Phase III Results In HER2-Positive Metastatic Breast Cancer Thursday, Mar 01, 2012 Genentech's ACTEMRA® Monotherapy Showed Superior Improvement in Rheumatoid Arthritis Signs and Symptoms Versus Adalimumab Monotherapy See the Archives 
 |
